![Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA](https://www.fda.gov/files/styles/recall_image_small/public/7_1.jpg?itok=YhMegWXb)
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA
![Helsinn Healthcare S. A. v. Teva Pharmaceuticals USA: Supreme Court Rules Secret Sales Could Bar Patent Eligibility Under the America Invents Act - Harvard Journal of Law & Technology Helsinn Healthcare S. A. v. Teva Pharmaceuticals USA: Supreme Court Rules Secret Sales Could Bar Patent Eligibility Under the America Invents Act - Harvard Journal of Law & Technology](https://jolt.law.harvard.edu/assets/digestImages/_digestHeader/supreme-court-546279_1920.jpg)
Helsinn Healthcare S. A. v. Teva Pharmaceuticals USA: Supreme Court Rules Secret Sales Could Bar Patent Eligibility Under the America Invents Act - Harvard Journal of Law & Technology
![Teva shutters New York, D.C. offices and dismisses lobbyists as part of U.S. consolidation drive | Fierce Pharma Teva shutters New York, D.C. offices and dismisses lobbyists as part of U.S. consolidation drive | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1519392364/teva1_1.jpg/teva1_1.jpg?VersionId=9yks0beA2l1CvdFeI0kPQH3NmrgKCHKU)
Teva shutters New York, D.C. offices and dismisses lobbyists as part of U.S. consolidation drive | Fierce Pharma
![Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S. | Business Wire Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S. | Business Wire](https://mms.businesswire.com/media/20220304005319/en/739014/22/teva_RGB_JPEG.jpg)
Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S. | Business Wire
![Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal](https://media.bizj.us/view/img/10278469/unknown-6*1200xx2016-1136-0-122.jpg)